vs

Side-by-side financial comparison of FIRST INDUSTRIAL REALTY TRUST INC (FR) and Harmony Biosciences Holdings, Inc. (HRMY). Click either name above to swap in a different company.

Harmony Biosciences Holdings, Inc. is the larger business by last-quarter revenue ($243.8M vs $194.8M, roughly 1.3× FIRST INDUSTRIAL REALTY TRUST INC). FIRST INDUSTRIAL REALTY TRUST INC runs the higher net margin — 75.9% vs 9.2%, a 66.7% gap on every dollar of revenue. On growth, Harmony Biosciences Holdings, Inc. posted the faster year-over-year revenue change (21.1% vs 10.0%). Over the past eight quarters, Harmony Biosciences Holdings, Inc.'s revenue compounded faster (25.6% CAGR vs 8.9%).

First Potomac Realty Trust was a real estate investment trust that invested in industrial properties and business parks in the suburbs of the Washington metropolitan area. In 2017, it was acquired by Government Properties Income Trust.

Harmony Biosciences Holdings, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for rare neurological and central nervous system disorders. Its primary market is the United States, with its core product serving patients living with narcolepsy and other sleep-related CNS conditions across adult and pediatric segments.

FR vs HRMY — Head-to-Head

Bigger by revenue
HRMY
HRMY
1.3× larger
HRMY
$243.8M
$194.8M
FR
Growing faster (revenue YoY)
HRMY
HRMY
+11.1% gap
HRMY
21.1%
10.0%
FR
Higher net margin
FR
FR
66.7% more per $
FR
75.9%
9.2%
HRMY
Faster 2-yr revenue CAGR
HRMY
HRMY
Annualised
HRMY
25.6%
8.9%
FR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FR
FR
HRMY
HRMY
Revenue
$194.8M
$243.8M
Net Profit
$147.9M
$22.5M
Gross Margin
71.9%
Operating Margin
15.8%
Net Margin
75.9%
9.2%
Revenue YoY
10.0%
21.1%
Net Profit YoY
179.7%
-54.6%
EPS (diluted)
$1.08
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FR
FR
HRMY
HRMY
Q1 26
$194.8M
Q4 25
$188.4M
$243.8M
Q3 25
$181.4M
$239.5M
Q2 25
$180.2M
$200.5M
Q1 25
$177.1M
$184.7M
Q4 24
$175.6M
$201.3M
Q3 24
$167.6M
$186.0M
Q2 24
$164.1M
$172.8M
Net Profit
FR
FR
HRMY
HRMY
Q1 26
$147.9M
Q4 25
$78.8M
$22.5M
Q3 25
$65.3M
$50.9M
Q2 25
$55.2M
$39.8M
Q1 25
$48.1M
$45.6M
Q4 24
$68.4M
$49.5M
Q3 24
$99.4M
$46.1M
Q2 24
$51.3M
$11.6M
Gross Margin
FR
FR
HRMY
HRMY
Q1 26
Q4 25
71.9%
Q3 25
75.1%
Q2 25
81.0%
Q1 25
82.7%
Q4 24
73.0%
Q3 24
77.0%
Q2 24
81.4%
Operating Margin
FR
FR
HRMY
HRMY
Q1 26
Q4 25
34.6%
15.8%
Q3 25
37.0%
27.3%
Q2 25
31.7%
24.0%
Q1 25
31.2%
30.4%
Q4 24
40.1%
27.7%
Q3 24
62.6%
33.2%
Q2 24
31.8%
12.4%
Net Margin
FR
FR
HRMY
HRMY
Q1 26
75.9%
Q4 25
41.8%
9.2%
Q3 25
36.0%
21.2%
Q2 25
30.6%
19.8%
Q1 25
27.2%
24.7%
Q4 24
39.0%
24.6%
Q3 24
59.3%
24.8%
Q2 24
31.3%
6.7%
EPS (diluted)
FR
FR
HRMY
HRMY
Q1 26
$1.08
Q4 25
$0.60
$0.38
Q3 25
$0.49
$0.87
Q2 25
$0.42
$0.68
Q1 25
$0.36
$0.78
Q4 24
$0.51
$0.85
Q3 24
$0.75
$0.79
Q2 24
$0.39
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FR
FR
HRMY
HRMY
Cash + ST InvestmentsLiquidity on hand
$775.3M
Total DebtLower is stronger
$163.7M
Stockholders' EquityBook value
$2.9B
$870.2M
Total Assets
$5.8B
$1.3B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FR
FR
HRMY
HRMY
Q1 26
Q4 25
$78.0M
$775.3M
Q3 25
$33.5M
$672.6M
Q2 25
$34.9M
$565.3M
Q1 25
$35.7M
$507.0M
Q4 24
$44.5M
$467.2M
Q3 24
$47.1M
$410.5M
Q2 24
$38.5M
$346.9M
Total Debt
FR
FR
HRMY
HRMY
Q1 26
Q4 25
$163.7M
Q3 25
$168.5M
Q2 25
$172.1M
Q1 25
$175.7M
Q4 24
$179.3M
Q3 24
$182.8M
Q2 24
$186.4M
Stockholders' Equity
FR
FR
HRMY
HRMY
Q1 26
$2.9B
Q4 25
$2.7B
$870.2M
Q3 25
$2.7B
$835.1M
Q2 25
$2.6B
$773.1M
Q1 25
$2.7B
$720.5M
Q4 24
$2.7B
$659.2M
Q3 24
$2.6B
$596.8M
Q2 24
$2.6B
$538.6M
Total Assets
FR
FR
HRMY
HRMY
Q1 26
$5.8B
Q4 25
$5.7B
$1.3B
Q3 25
$5.5B
$1.2B
Q2 25
$5.5B
$1.1B
Q1 25
$5.4B
$1.1B
Q4 24
$5.3B
$999.2M
Q3 24
$5.2B
$928.1M
Q2 24
$5.2B
$858.4M
Debt / Equity
FR
FR
HRMY
HRMY
Q1 26
Q4 25
0.19×
Q3 25
0.20×
Q2 25
0.22×
Q1 25
0.24×
Q4 24
0.27×
Q3 24
0.31×
Q2 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FR
FR
HRMY
HRMY
Operating Cash FlowLast quarter
$126.2M
Free Cash FlowOCF − Capex
$126.0M
FCF MarginFCF / Revenue
51.7%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
5.61×
TTM Free Cash FlowTrailing 4 quarters
$347.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FR
FR
HRMY
HRMY
Q1 26
Q4 25
$461.3M
$126.2M
Q3 25
$124.6M
$108.7M
Q2 25
$126.1M
$79.3M
Q1 25
$88.6M
$34.0M
Q4 24
$352.5M
$75.6M
Q3 24
$105.5M
$70.5M
Q2 24
$107.7M
$42.6M
Free Cash Flow
FR
FR
HRMY
HRMY
Q1 26
Q4 25
$126.0M
Q3 25
$108.7M
Q2 25
$79.3M
Q1 25
$33.9M
Q4 24
$75.0M
Q3 24
$70.5M
Q2 24
$42.0M
FCF Margin
FR
FR
HRMY
HRMY
Q1 26
Q4 25
51.7%
Q3 25
45.4%
Q2 25
39.6%
Q1 25
18.3%
Q4 24
37.3%
Q3 24
37.9%
Q2 24
24.3%
Capex Intensity
FR
FR
HRMY
HRMY
Q1 26
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.3%
Q3 24
0.0%
Q2 24
0.4%
Cash Conversion
FR
FR
HRMY
HRMY
Q1 26
Q4 25
5.85×
5.61×
Q3 25
1.91×
2.14×
Q2 25
2.28×
1.99×
Q1 25
1.84×
0.75×
Q4 24
5.15×
1.53×
Q3 24
1.06×
1.53×
Q2 24
2.10×
3.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons